Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey.

Delia BogdanetCatriona ReddinEsther MackenTomas P GriffinNarjes FhelelboomLinda BiestyShakila ThangaratinamEugene DempseyCaroline CrowtherSander GaljaardMichael MareshMary R LoekenAngela NapoliEleni AnastasiouEoin NoctorHarold W de ValkMireille N M van PoppelAndrea AgostiniCheril ClarsonAoife M EganPaula M O'SheaDeclan DevaneFidelma P Dunne

Published in: Diabetologia (2019)

This study identified a COS that will help bring consistency and uniformity to outcome selection and reporting in clinical trials and other studies involving the follow-up at 1 year and beyond of women diagnosed with GDM treated with insulin and/or oral glucose-lowering agents during pregnancy.

Keyphrases

type diabetes
clinical trial
blood glucose
glycemic control
polycystic ovary syndrome
cross sectional
emergency department
adverse drug
blood pressure
pregnant women
phase ii